Why is Third Point shorting Nu Skin?
After supporting the much-maligned Herbalife, activist investor Dan Loeb bets against a similar multi-level marketer.
Activist investor Dan Loeb, who runs the Third Point hedge fund, has taken a short position in Nu Skin (NUS), a multi-level marketing company that sells anti-aging products, reports the New York Post.
It's a bit of an about-face for Third Point, which was revealed earlier this month to have taken a stake in Herbalife (HLF), a company targeted by well-known short-seller Bill Ackman as a "pyramid scheme."
It appears that Loeb is "playing both sides of the mutilevel-marketing field," the Post writes. Both Nu Skin and Herbalife sell their products in a similar way, with distributors profiting by recruiting more people.
Third Point reportedly took a "sizable" short position in Nu Skin, with its research into the company stemming back to 2011. Loeb is said to have a "dim view" of Nu Skin, although a representative for the hedge fund declined to comment to the Post.
At the heart of the issue is concerns about Nu Skin's expansion to China, which bans multi-level marketing plans.
Those concerns are similar to ones aired by Citron Research last summer in a report that alleged Nu Skin was operating multi-level "and/or pyramid sales activity in China, both expressly forbidden by law in that country."
According to Citron, one of its contacts attended a Nu Skin conference in the Chinese city of Hefei, where the company's speaker explained its structure as "like a pyramid." Its report also flagged alleged "flimsy and unsubstantiated medical claims."
After Citron released the report in August, its shares took a beating, although they have since recovered. Since the start of 2013, its stock is up 21%.
Loeb's Third Point was revealed to have bought 8.9 million shares of Herbalife earlier this month, while Ackman's Pershing Square has a short position of more than 20 million shares.
More on moneyNOW
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
More than 8,000 households got hit with the one-time levy as Socialist President Francois Hollande continues to target the nation's wealthiest.
- Farmers cultivate drones as new high-tech tool
- Apple's overseas hoard unfair to taxpayers
- Why hugely profitable ESPN is laying off workers
- Tornado shelters become a vital business
- Victoria's Secret won't sell cancer 'survivor' bras
- DC is doing nothing to fix the economy
- Models have it easier getting into US than engineers
- Bernie Madoff earns sweatshop wages in prison
- Motor home sales rise in hopeful economic sign
[BRIEFING.COM] Stocks ended modestly higher as the S&P 500 climbed 0.2%, and the Dow added 0.4% to register its 19th consecutive Tuesday of gains.
The major averages saw little change during morning action, but afternoon buying interest helped lift the indices to session highs. Most cyclical sectors (with the exception of materials and technology) finished among the leaders, but the defensively-geared health care sector settled atop the leaderboard as biotechnology outperformed. ... More
More Market News
The auto parts giant beats Wall Street expectations, while continuing to expand its stores in the U.S. and Mexico.